Leadership
Kihealth combines deep scientific expertise with experienced leadership across clinical development, technology, commercialization, and company building.
Executive leadership
Strategy, capital formation, operations, partnerships and clinical direction.
Chief Executive Officer & Co-Founder
Translates Kihealth’s scientific advantage into an executable growth strategy spanning commercialization, capital formation and strategic expansion. Brings more than two decades of experience building and scaling healthcare, biotechnology and digital-health organizations, including executive roles at AccessElite, Concierge Key Health, ALPHAEON Corporation and Allergan.
Chief Operations Officer & Co-Founder
Builds the operating and partnership infrastructure required to scale Kihealth, integrating business development, strategic alliances, government affairs and corporate growth. Brings six years of experience in the United States Congress and senior leadership roles in Florida state government, with deep expertise in healthcare policy and regulatory strategy.
Chief Medical Officer
Board-certified pediatric endocrinologist and nationally recognized diabetes specialist. Medical Director of the Northeast Florida Pediatric Diabetes Center at Nemours Children's Health, leading clinical strategy, research, regulatory engagement and product development.
Scientific & clinical leadership
Scientific strategy, assay development, laboratory operations, quality systems and translational research.
Chief Scientific Officer
Molecular biologist and diagnostics innovator with extensive experience in biomarker discovery, translational research and assay development. Leads scientific strategy, research collaborations and platform expansion across the Kihealth portfolio.
Laboratory Director
Laboratory physician and molecular diagnostician responsible for clinical laboratory operations, quality systems, assay implementation and regulatory compliance across Kihealth's high-complexity laboratory.
Vice President, Research & Development
Leads research and development, assay design, analytical validation, platform optimization and translational research — bridging scientific innovation with real-world clinical deployment.
Scientific & clinical advisors
Advisory, non-executive roles. Advisors guide biomarker discovery, program data review and clinical study design; they are distinct from company management.
Scientific Advisor
Professor of Immunobiology & Medicine, Yale School of Medicine
World-leading authority in Type 1 diabetes prevention and immunotherapy, central to the development of teplizumab and to the foundational science underpinning Kihealth's platform.
Scientific Advisor
Director Emeritus, Diabetes Research Institute, University of Miami
Internationally renowned physician-scientist and pioneer in diabetes research, regenerative medicine and cellular transplantation.
Scientific Advisor
Director of Business Development, Harvard University
Dual focus on scientific innovation and biotechnology business strategy, advising on translational programs and partnership development.
Clinical Advisor
Chief of Pediatric Endocrinology, Nemours Children's Health
More than 34 years in pediatric endocrinology and clinical research, with a focus on integrating novel diagnostics into routine care pathways.
Clinical Advisor
Endocrinologist, Cedars-Sinai Medical Center
Board-certified endocrinologist combining evidence-based care with advances in precision metabolic medicine.
Board of directors
Capital-markets discipline paired with operators who have scaled category-defining companies — guiding strategy, governance and long-horizon value creation.
Chairman of the Board
Founder, ThinkTank Holdings · Founder, Buy.com
Entrepreneur and founder of ThinkTank Holdings LLC, a private investment firm focused on technology, commerce and media. Founder of Buy.com, one of the earliest large-scale e-commerce platforms, with deep experience scaling category-defining ventures.
Board Member
Kramer-Wilson Company · fmr. CFO, KW Specialty Insurance
Financial strategist and California CPA with a career spanning corporate finance, public accounting and investment management. Founding CFO of KW Specialty Insurance, built to a $101M statutory surplus and an A.M. Best A- (Excellent) rating.
Board Member
Founder & CEO, Alcedo Capital · fmr. MD, MDB Capital Group
Biotechnology and investment leader. PhD in Biophysics (University of Virginia) and JD (George Washington University Law School). Previously Managing Director at MDB Capital Group, funding disruptive technology companies.
Leadership philosophy
01
Analytical validity, peer-reviewed evidence and transparent data practices behind every claim.
02
Ethics, transparency and quality standards appropriate to diagnostic medicine.
03
Built alongside clinicians, researchers, academic institutions and industry partners.
04
Breakthrough biology converted into validated assays and real-world clinical tools.
05
Diagnostics designed to reduce uncertainty and accelerate intervention for patients.
06
Clinical validation and published findings guide the path to commercialization.
A team built to carry molecular science from discovery through commercial scale.
